{
  "main_header": {
    "sid": 1002949,
    "name": "Bharat Parenter.",
    "stock_name": "Bharat Parenter.",
    "full_name": "Bharat Parenterals Ltd",
    "name_url": "stocks-analysis/bharat-parenter",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,351.10",
    "chg": -28.9,
    "chgp": "-2.09%",
    "dir": -1,
    "prev_price": "1,380.00",
    "mcapval": "951.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541096,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE365Y01019",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": 110,
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/bharat-parenter-1002949-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Bharat Parenterals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bharat-parenterals-ltd-latest-results-good-or-bad-3999564",
        "imagepath": "",
        "date": "2026-05-19 19:21:30",
        "description": "Bharat Parenterals Ltd's latest financial results for Q4 FY26 reflect a company facing significant operational challenges. The consolidated net loss for the quarter stood at ₹4.80 crores, which represents a slight improvement in terms of a lower loss compared to the previous quarter. However, this figure indicates persistent difficulties in achieving profitability. \n\nNet sales for the quarter were reported at ₹99.62 crores, showing a sequential increase of 52.81% from the previous quarter, but this figure is still 4.19% lower than the same quarter last year. This revenue volatility suggests inconsistent demand and potential issues with customer retention in the pharmaceutical sector.\n\nThe operating margin, excluding other income, was negative at -0.53%, marking the lowest level in recent quarters. This reflects a significant decline from the previous year's operating margin of 11.88%, indicating severe pres..."
      }
    ],
    "total": 15,
    "sid": "1002949",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/bharat-parenterals-1002949"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Copy of newspaper advertisement for the Unaudited Financial Results for the Quarter ended on June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter Ended On June 30 2026",
      "datetime": "05-Aug-2026",
      "details": "Unaudited Financial Results for the quarter ended on June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "05-Aug-2026",
      "details": "Re-appointment of Mr. Hemang Shah as Executive Director of the Company Subject to approval of Shareholders in enuing AGM.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bharat Parenterals Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Bharat Parenterals Ltd latest results good or bad?

2026-05-19 19:21:30

Bharat Parenterals Ltd's latest financial results for Q4 FY26 reflect a company facing significant operational challenges. The consolidated net loss for the quarter stood at ₹4.80 crores, which represents a slight improvement in terms of a lower loss compared to the previous quarter. However, this figure indicates persistent difficulties in achieving profitability. Net sales for the quarter were reported at ₹99.62 crores, showing a sequential increase of 52.81% from the previous quarter, but this figure is still 4.19% lower than the same quarter last year. This revenue volatility suggests inconsistent demand and potential issues with customer retention in the pharmaceutical sector. The operating margin, excluding other income, was negative at -0.53%, marking the lowest level in recent quarters. This reflects a significant decline from the previous year's operating margin of 11.88%, indicating severe pres...

Read More

View All News